Article Figures & Data
Figures
- Fig 1.
Distribution of Wilcoxon scores for CP in pretreatment patients. We see significantly lower CP in pretreatment patient tumors that overexpress EGFR.
- Fig 2.
Distribution of Wilcoxon scores for CP in pretreatment patients. There is a trend toward higher CP in tumors that overexpress p16 and are HPV-positive.
- Fig 3.
Distribution of Wilcoxon scores for CP in pretreatment versus palliative patients. Pretreatment patients have significantly lower CP scores versus palliative patients.
- Fig 4.
Distribution of Wilcoxon scores for BF in pretreatment versus palliative patients. We see that pretreatment patients have significantly higher BF versus palliative patients.
Tables
- Table 1:
CTP parameter mean (95% CI) overall in pretreatment and palliative groups combined
CTP Parameter Mean (95% CI) BF 103.7 (73.6–133.7) BV 11.8 (3.7–19.9) CP 27.4 (19.4–35.4) MTT 7.6 (6.4–8.8) Note:—CI indicates confidence interval.
- Table 2:
CTP parameter mean (95% CI) by marker status in pretreatment and palliative groups combined
Positive Negative P Valuea HPV (n = 5) (n = 19) BF 121.4 (56.8–186.1) 101.6 (63.5–139.6) .53 BV 8.2 (5.1–11.4) 13.2 (2.4–24.0) .97 CP 30.4 (9.8–51.1) 27.3 (17.4–37.2) .67 MTT 7.4 (3.3–11.6) 7.8 (6.5–9.1) .52 EGFR n = 15 n = 5 BF 108.7 (60.5–156.9) 105.4 (42.5–168.2) .66 BV 14.7 (0.8–28.6) 7.4 (5.4–9.4) .93 CP 27.1 (16.7–37.6) 37.3 (5.4–69.2) .79 MTT 7.0 (5.4–8.5) 7.8 (3.9–11.7) .22 Note:—CI indicates confidence interval.
↵a P value derived from the Wilcoxon 2-sample test.
CTP Parameter Mean (95% CI) BF 124.2 (87.4, 160.9) BV 8.4 (6.1, 10.7) CP 19.9 (15.8, 24.0) MTT 7.1 (5.7, 8.5) Note:—CI indicates confidence interval.
CTP Parameter Positive Negative P Valuea HPV n = 4 n = 13 BF 134.5 (55.2–213.8) 126.3 (77.0–175.7) .69 BV 8.2 (3.5, 12.8) 8.9 (5.9–12.0) .95 CP 23.5 (12.0–35.0) 19.4 (14.1–24.6) .14 MTT 7.3 (1.2–13.3) 7.2 (5.6–8.8) .95 EGFR n = 10 n = 4 BF 137.1 (70.2–204.0) 108.8 (16.9–200.7) .72 BV 8.7 (4.4–13.1) 7.0 (4.4–9.7) .94 CP 16.2 (11.8–20.7) 26.7 (8.9–44.4) .04 MTT 5.8 (4.3–7.3) 7.9 (2.1–13.7) .44 Note:—CI indicates confidence interval.
↵a P value derived from the Wilcoxon 2-sample test.
